Popular products by category
Rigaku nano3DX is a true X-ray microscope (XRM) with ultra-wide field of view, 25X larger volume than comparable systems, and three X-ray wavelengths for different matrices.Read more...
HyPix-3000 is a next-generation two-dimensional hybrid pixel array semiconductor detector designed specifically to meet the needs of the home lab diffractionist.Read more...
Analytical solutions by industry
New papers of interest
Special Feature: Pharmaceutical Analysis (5): Analysis of trace impurities in pharmaceutical products using polarized EDXRF spectrometer NEX CG.Read more...
Non-destructive evaluation of pseudo-polymorphic impurities in a drug tablet
In the tableting process of a pharmaceutical product, the drug sometimes reacts with excipients (inactive substances used as carriers for the drug) such as sugar and starch, or the process induces a dehydration reaction or a polymorphic transition. Scientists involved in the pharmaceutical industry need to determine—as quickly as possible—whether a drug of interest maintains its original crystalline system during the tableting process or if polymorphic impurities are produced.
A model sample was created in which a part of the original drug substance was converted in to a polymorphic impurity when making tablets. Theophilline anhydride, a tracheal relaxant, was combined with theophilline monohydrate as a pseudo-polymorphic impurity. A double-weight standard excipient (a mixture of lactose and starch) was added and the resulting powder was cast into a tablet 6 mm in diameter and 3 mm thick.
The tablet was measured just as it is without destroying it, using a TTRAX III θ/θ rotating anode XRD system. By combining the parallel beam and transmission techniques available in Rigaku's Cross Beam Optics system, precise diffraction profiles can be obtained independent of the sample shape. This makes it possible to detect and use the diffraction lines from both the outside and the inside of the tablet.
As shown in Figure 1, even when the polymorphic impurity in the original drug substance is as low as 1 wt% (0.3 wt% for the total weight of the tablet), it can be detected with a measurement of about 10 minutes.
A calibration curve, Figure 2, that has a high correlation with the original drug substance was obtained.
Samples provided by Professor Katsuhide Terada, Pharmaceutical sciences, TOHO University